BioLineRx Ltd. (BLRX) Insider Trading Disclosures
BioLineRx Ltd. (BLRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BLRX
CIK: 1498403
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kesselman & Kesselman C.P.A.s
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerBatia Ron
Audit LocationTel-Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-02 | — | EFFECT Filing | 9999999995-26-003144 | View SEC Doc Filr Page |
| 424B3 | 2026-10-02 | — | 424B3 | 0001178913-26-004697 | View SEC Doc Filr Page |
| F-1 | 2026-09-25 | — | F-1 | 0001178913-26-004612 | View SEC Doc Filr Page |
| 6-K | 2026-09-24 | 2026-09-24 | 6-K | 0001178913-26-004591 | View SEC Doc Filr Page |
| 6-K | 2026-09-10 | 2026-09-10 | 6-K | 0001178913-26-004479 | View SEC Doc Filr Page |
| D | 2026-09-09 | — | D Filing | 0001178913-26-004469 | View SEC Doc Filr Page |
| 424B5 | 2026-08-31 | — | 424B5 | 0001178913-26-004339 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-08-31 | 6-K | 0001178913-26-004334 | View SEC Doc Filr Page |
| 6-K | 2026-08-31 | 2026-06-30 | 6-K | 0001178913-26-004331 | View SEC Doc Filr Page |
| 6-K | 2026-08-28 | 2025-08-28 | 6-K | 0001178913-26-004292 | View SEC Doc Filr Page |
| 6-K | 2026-08-18 | 2026-08-18 | 6-K | 0001178913-26-004184 | View SEC Doc Filr Page |
| 6-K | 2026-07-08 | 2026-07-08 | 6-K | 0001178913-26-003438 | View SEC Doc Filr Page |
| 6-K | 2026-05-27 | 2026-05-27 | 6-K | 0001178913-26-002934 | View SEC Doc Filr Page |
| 6-K | 2026-05-22 | 2026-05-22 | 6-K | 0001178913-26-002876 | View SEC Doc Filr Page |
| 6-K | 2026-05-19 | 2026-05-19 | 6-K | 0001178913-26-002789 | View SEC Doc Filr Page |
| 6-K | 2026-04-28 | 2026-04-28 | 6-K | 0001178913-26-002262 | View SEC Doc Filr Page |
| 3 | 2026-04-10 | 2026-03-18 | 3 Filing | 0001178913-26-002057 | View SEC Doc Filr Page |
| 3 | 2026-03-31 | 2026-03-18 | 3 Filing | 0001178913-26-001963 | View SEC Doc Filr Page |
| 3 | 2026-03-31 | 2026-03-18 | 3 Filing | 0001178913-26-001961 | View SEC Doc Filr Page |
| 3 | 2026-03-31 | 2026-03-18 | 3 Filing | 0001178913-26-001959 | View SEC Doc Filr Page |
| 3 | 2026-03-31 | 2026-03-18 | 3 Filing | 0001178913-26-001958 | View SEC Doc Filr Page |
| 3 | 2026-03-30 | 2026-03-18 | FORM 3 | 0001178913-26-001893 | View SEC Doc Filr Page |
| 3 | 2026-03-30 | 2026-03-18 | FORM 3 | 0001178913-26-001890 | View SEC Doc Filr Page |
| 20-F/A | 2026-03-27 | 2025-12-31 | 20F/A | 0001178913-26-001807 | View SEC Doc Filr Page |
| 3 | 2026-03-27 | 2026-03-18 | FORM 3 | 0001178913-26-001790 | View SEC Doc Filr Page |